00:01
Pancreatic cancer.
00:02
Second most common GI cancer.
00:05
We have cancers such as primary
gastric adenocarcinoma.
00:09
We have colorectal cancer,
all being part of GI, and
pancreatic cancer, second
most common GI cancer.
00:16
When you say pancreatic cancer,
here, we’re referring to
adenocarcinoma of the pancreas.
00:21
Adenocarcinoma.
00:23
Remember when it comes to the
pancreas, you’ll be dividing it
into an adenocarcinoma, and
your Islet cell tumor cancers.
00:30
For example, most common,
Islet cell tumor, a beta
islet cell tumor, a benign
cancer called insulinoma.
00:39
This is adenocarcinoma.
00:43
Risk factors.
00:45
Family history plays a big role.
00:46
Smoking plays a big role.
00:48
Molecularly,
what kind of RAS is associated with
pancreatic cancer?
Good.
00:55
K-ras.
00:57
It is an adenocarcinoma.
01:00
Endocrine tumor.
01:02
A cystic tumor.
01:03
Or a lymphoma. All different
types of pancreatic cancers.
01:08
Our focus in this section
will be adenocarcinoma.
01:11
Remember the endocrine tumors;
a beta Islet cell tumor,
an alpha Islet cell tumor,
a delta Islet cell tumor
referring to insulinoma, glucagonoma,
somatostatinoma that we’ve
discussed all prior.
01:23
You could have cystic tumors,
and perhaps even, lymphomas.
01:28
Clinical presentation of pancreatic cancer
is what you would expect with pancreatitis.
01:34
Abdominal pain with the
radiation to the back.
01:37
There is going to be
weight loss, but you will
also find this with
chronic pancreatitis.
01:43
If it’s adenocarcinoma,
which actually for you,
would be more found or located
in the head of the pancreas.
01:51
Please put the head of the pancreas
and jaundice manifestation together.
01:56
The head of the pancreas is nestled
within the second part of the duodenum.
02:02
If you go on to develop an adenocarcinoma
of the head, as it enlarges,
it is then going to cause obstruction
in the area of the intestine.
02:12
What happens now?
Obstruction.
02:14
You cannot properly dump out your bile
into the second part of the duodenum.
02:19
This is an obstructive type of jaundice.
02:25
Courvoisier's sign is the
name, but what it means
is the fact that the
gallbladder may be palpable,
which is rather interesting, isn’t it?
The gallbladder which is
behind the liver ends up --
You find a description where upon
physical examination, it’s palpable,
high on the differential at that point
should be some kind of GI cancer.
02:45
Clinical presentation continues and now we
have something called Trousseau Syndrome.
02:50
And those of you that have
memorized Trousseau sign,
meaning to say your Chvostek
sign or something like your
carpopedal spasms after
placing a blood pressure cuff
This is not that.
03:05
This is a Trousseau
syndrome, and what this
means is you’re a migratory
type of thrombosis.
03:11
A venous thrombosis that you would find.
03:13
This is called Trousseau’s syndrome.
03:16
Also, there might be variceal
hemorrhage from portal hypertension.
03:20
Remember, with pancreatic
cancer, there’s every
possibility that you might
have portal hypertension.
03:26
And with all of this, sequelae
of portal hypertension,
it’s the variceal hemorrhage
that you’re worried about the most.
03:33
And with enough damage that’s
taken place to pancreas
at some point in time,
you’re expect there to be
glucose intolerance due to
decreased insulin release.
03:43
Important. Important clinical
presentations for pancreatic cancer.
03:48
And why?
Specifically is because you
cannot afford to get this
confused with chronic
pancreatitis in which weight loss
could also be found,
also with hypoglycemia.
03:59
But these others things such as your
Trousseau syndrome and such,
mm-mm.
04:06
Pancreatic cancer and our evaluation of it.
04:09
How do we diagnose it?
You’re going to be looking for CA 19-9.
04:14
Serum levels of a CA 19-9 have a high sensitivity and specificity for patients presenting with classic symptoms of a GI malignancy.
04:22
But there are poor screening test, when used in the general population.
04:25
For example you can see non-specific elevations in patients that present with obstructive jaundice for elated the gallstones.
04:32
Remember, they are going
to give you a number of
signs and symptoms so that
it points you towards
pancreatic cancer.
04:39
They will give you CA 19-9.
04:41
And at that point, you should be
thinking about pancreatic cancer.
04:44
No doubt.
04:46
Radiologically, what are you going to find?
Well, you do a high resolution
CT with pancreatic protocol used
for staging, staging, staging when
it comes to pancreatic cancer.
04:57
You wouldn’t find such a thing
as your pseudocyst and such.
05:00
A pseudocyst is something
that you would find with
pancreatitis more notably
with chronic pancreatitis.
05:09
Your endoscopic ultrasound.
05:11
What are you going to find?
What are you looking for?
So at this point, you are
suspecting pancreatic cancer.
05:16
Why?
Well, because there is glucose
intolerance, there is jaundice
in your patient, and you end up
finding a marker for CA19-9.
05:24
Exploration.
05:25
Ultrasound.
05:26
Localization of the tumor and
staging, endoscopic ultrasound.
05:31
The ERCP becomes important for therapeutic
stenting for obstructive jaundice.
05:36
Okay?
So even to this day, as
far as you’re concerned,
you’re going to use
ERCP at certain times,
especially because if you
want to open up things,
to explore for certain pathologies and
understand that this might actually
cause damage as well, referring to
the fact that earlier, a cause of
pancreatitis was in fact ERCP.
05:57
Management.
05:58
Surgery, only curative option.
06:01
Steve Jobs from Apple died
of pancreatic cancer.
06:05
It is extremely aggressive.
06:07
And even with surgery,
there is no guarantee that
the patient is going to live.
06:13
A five-year survival rate remains
very poor even after surgery.
06:18
And, let me bring up a
basic concept that we
talked about in our
discussion of neoplasia.
06:24
And at the time, I told you
that adenocarcinoma
is involved with a particular
type of change around the cancer
that gives it a fibrous
type of consistency.
06:38
What’s that called?
Desmoplasia.
06:41
Interesting phenomenon, isn’t it?
You could find that with
pancreatic cancer big time.
06:47
Palliation:
Endoscopic or percutaneous stent.
06:51
What are you trying to do?
You’re trying to open up
perhaps a blocked duct,
chemotherapy with a drug
called gemcitabine,
and pain control with the celiac
nerve block, if at all, effective.